Skip to main content

Table 4 Correlation between MiR-130b and patient clinicopathological characteristics

From: MicroRNA-130b promotes lung cancer progression via PPARγ/VEGF-A/BCL-2-mediated suppression of apoptosis

Items MiR-130b (N = 91) p
Low (N = 46) High (N = 45)  
Gender    0.929
  Male 19 19  
  Female 27 26  
Smoking Status    0.303
  Nonsmoker 12 7  
  Smoker 34 38  
Tumor Location    0.327
  Central 21 16  
  Peripheral 25 29  
Differentiation    0.002
  High 31 16  
  Moderate-Poor 15 29  
LN Metastasis    0.026
  Yes 33 22  
  No 13 23  
Tumor Size    0.002
  >3 cm 36 21  
  <3 cm 10 24  
TNM Stage    0.025
  I-II 25 14  
  III-IV 21 31  
  1. p values listed are derived from χ2 test